IP Library › Granted Patent US 12,290,417
Granted Patent B1
US 12,290,417 · App. 19/000,663 · Granted May 6, 2025

Multi-axis tumor margin marker system

Inventor: Robert I. Hacker (Frontenac, MO)
A61B90/39A61B2090/3908A61B2090/3966A61B2090/3987A61B2090/3991
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,290,417
App. No.
19/000,663
Granted
May 6, 2025
Kind
B1
Abstract

A multi-axis tumor excision marker system is configured to deposit markers along multiple axes radially about a tumor to define a boundary of margin tissue for excision. A catheter may deploy a marker extension that extends to a margin tissue boundary for depositing the marker. The marker extension may be a shape memory material that extends radially outward from catheter opening or may be directed radially outward by a guide head. The radiopaque marker may be a phase change marker, such as an adhesive that changes from a liquid to a solid. A marker may be a discrete marker and may have an extension portion that extends from an anchor portion. An envelopment marker has a plurality of marker extensions that each extend along an offset axis from each other. A spiral maker includes a maker extension that spirals around the margin boundary tissue.

Claims (20)

1. A multi-axis tumor marker system comprising:

a) a catheter having a proximal and a distal end with a distal end opening;

b) a marker extension configured to retain a marker and extend from the distal end opening of the catheter for depositing said marker;

wherein the marker is deposited along multiple axes radially about a tumor to define a boundary of margin tissue for excision;

wherein the marker extension comprises an axial marker-extension configured to extend axially from the distal end opening of the catheter to deposit said marker along a catheter axis;

wherein the axial marker-extension is configured to deposit said marker on a distal end of said boundary of said margin tissue to produce a distal marker; and

a plurality of radial marker-extensions, each extending within the catheter and containing a radial marker;

wherein each of the plurality of radial marker-extensions is configured to extend radially out from the distal end opening of the catheter when pushed out from said distal end opening; and

wherein each of the plurality of radial marker-extensions is configured to deposit said radial marker on a radial boundary of said margin tissue; and

wherein a zero degree radial marker-extension of the plurality of radial marker-extensions is configured to extend in a zero degree radial direction from the distal end opening and wherein a 180 degree radial marker-extension of the plurality of radial marker-extensions is configured to extend substantially 180 degrees from the zero degree radial marker-extension; and

a 90 degree radial marker-extension of the plurality of radial marker-extensions that is configured to extend substantially 90 degrees from the zero degree radial marker-extension and further comprising a 270 degree radial marker-extension of the plurality of radial marker-extensions that is configured to extend substantially 270 degrees from the zero degree radial marker-extension.

2. The multi-axis tumor marker system of claim 1 , further comprising a guide head configured to guide the marker-extensions radially outward, said guide head comprising a radial guide along a radial guide aperture.

3. The multi-axis tumor marker system of claim 1 ,

wherein the marker is a phase change marker and wherein the phase change marker is a liquid in the marker extension and wherein the phase change marker changes to a solid upon deposition in said margin tissue.

4. The multi-axis tumor marker system of claim 1 , wherein the phase change marker comprises a radiopaque material.

5. The multi-axis tumor marker system of claim 1 , wherein the phase change marker comprises an adhesive.

6. The multi-axis tumor marker system of claim 5 , wherein the phase change marker comprises a radiopaque material.

7. The multi-axis tumor marker system of claim 5 , wherein the phase change marker comprises a cyanoacrylate adhesive.

8. The multi-axis tumor marker system of claim 7 , wherein the phase change marker comprises a radiopaque material.

9. The multi-axis tumor marker system of claim 1 , wherein the marker-extension comprises shape memory metal that is configured to extend radially outward from the distal end opening of the catheter.

Continuity (2)
Continuation PCTUS2024016778 · Feb 21, 2024
Provisional Application 63447334 · Feb 21, 2023
References Cited (19)
US 6146373A · Cragg · 2000 [cited by examiner]
US 6161034A · Burbank et al. · 2000 [cited by applicant]
US 7524374B2 · Patrick et al. · 2009 [cited by applicant]
US 8114006B2 · Fox et al. · 2012 [cited by applicant]
US 8600481B2 · Sirimanne et al. · 2013 [cited by applicant]
US 10286114B2 · Hermann et al. · 2019 [cited by applicant]
US 11219502B2 · Liu · 2022 [cited by applicant]
US 11324567B2 · Liu · 2022 [cited by applicant]
US 20020193677A1 · Thornton · 2002 [cited by applicant]
US 20060235365A1 · Terwilliger et al. · 2006 [cited by applicant]
US 20100204570A1 · Lubock · 2010 [cited by examiner]
US 20110004094A1 · Stubbs · 2011 [cited by examiner]
US 20150148837A1 · Shinar · 2015 [cited by examiner]
US 20190076212A1 · Liu · 2019 [cited by examiner]
US 20190231473A1 · Liu · 2019 [cited by examiner]
US 20200085497A1 · Zhang et al. · 2020 [cited by applicant]
US 20210114088A1 · Hennessy et al. · 2021 [cited by applicant]
US 20210275276A1 · Habibi · 2021 [cited by examiner]
US 20220218392A1 · Gross et al. · 2022 [cited by applicant]